3SOF

Good going man...made some $$$...That is what it is all about Yeah, watch for dips especially if we gap open like I think we will, especially with any news...GLTY

Quote from: armor00 on March 07, 2006, 01:03:02 AM
Excellent info Gateway, I really appreciate your input on this stock and only bought in cause of your analysis" didnt have time to do my own research".  I pulled out at .025 for a 54% gain, I made the mistake of looking at Level II and didnt think it was going to go up higher. I will be looking to get back in if it pulls back any tomorrow.

XKEM: @ .03 +20% Berlin Exchange 3/7/06

HOD .0297. 144,750,000 million shares traded... .0259 +4% 

Still under heavy accumulation; Market cap still only 6.7 million. 

Expecting follow-up news to the news released friday, but not by the company. I will re-post it below. GLTA

Friday News Repost:

XKEM ------- March 3rd, 2006

Obasanjo to launch locally produced sickle cell drug

President Olusegun Obasanjo will by June launch NIPRISAN (HEMOXIN(TM)), the locally produced drug for sickle cell disorder.
PATIENCE OGBE Abuja

The president will also use the occasion to commission Xechem International Inc. factory in the country in a move seen as a landmark investment in Nigeria. The company owns the exclusive rights to NIPRISAN

The drug NIPRISAN (HEMOXIN(TM), which is at present, undergoing final stage of registration with NAFDAC is a phyto-pharmaceutical drug for the treatment of patients suffering from Sickle Cell Disease (SCD). SCD is an insidious and painful genetic blood disorder often resulting in death at an early age.

Science and Technology Minister, Turner Isoun who disclosed this in Abuja noted that location of the factory in Nigeria would further crash the price of sickle cell drugs in Nigeria.

Isoun stated that Niprisan (HEMOXIN(TM)) was a drug cocktail, with phyto-pharmaceutical composition of four traditional plants extracted in a proprietary process. The licensor of the technology is the National Institute for Pharmaceutical Research and Development (NIPRD) in Abuja, Nigeria.

Nigeria is said to have the highest sickle cell disease population in the world ranging from four to six million representing roughly three to five percent of the country's population.

Isoun spoke at the inaugural meeting of the Ministers' Council for the National Biotechnology Development Agency (NABDA) where he also called on the government to involve more laboratories for the control and analysis of the bird flu menace.

On the situation of bio technology in Nigeria, he called on the stockholding agencies to ensure that Nigeria benefits from the judicious and safe use of modern biotechnology.

"Biotech is a gold mine and important to this nation. Almost every Nigerian is affected by the operations of biotech. To be able to achieve all these, we will require the concerted political will and a focused leadership drive. It is therefore the collective responsibility of all of us key stakeholders of modern biotechnology to join forces in realizing this vision.

It is my belief that this collective mission will not jeopardize our separate mandates but will promote the effective coordination of our effort towards achieving the same ultimate goal."

To achieve the nation's targets in biotech, the Director General of the National Biotechnology Development Agency (NABDA), Bamidele Solomon called for the establishment of biotechnology development fund.

The fund, he stressed, could help the nation support competent researches and be ready to tackle problems like the bird flu.

He also disclosed that Nigeria in collaboration with Trinity Biotech of the Republic of Ireland will establish a facility at SHESTCO Abuja for the production of test kits for HIV/AIDS and other diseases like HB, malaria and so on.

He added that the Federal Government has approved the sum of $28 million as counterpart commitment for the project.

He also spoke of Nigeria's collaboration with Shantha Biotechnics Limited of India for the establishment a facility for the production of Hepatitis B vaccine and other vaccines for related diseases like typhoid, polio, DTP and related ailments.

"Government approved the sum of N10 Million in the 2004 capital budget to support carrying out of a detailed feasibility study and fulfilling other MoU requirement."

hey gatewaystocks, nice winner going here eh? Definitely turning a mint on it, looking for more from it.

Still holding my positions.
hehe,first target .27.......still long way to go.

GatewayStocks has been on top of this one.
May get a second attempt to go at that golden cross, 50/200 dma crossover.
Here is the chart guys and gals.

Nice chart...Still under heavy accumulation....GLTA

Quote from: setravis on March 07, 2006, 11:13:13 PM
GatewayStocks has been on top of this one.
May get a second attempt to go at that golden cross, 50/200 dma crossover.
Here is the chart guys and gals.

Stockguru.com: Guru Alerts XKEM for Wednesday, March 8, 2006 - XKEM

Wednesday, March 08, 2006 07:52 ET

Dallas, Texas, Mar 08, 2006 (M2 PRESSWIRE via COMTEX) -- Stock Guru Alerts for Wednesday Xechem International, Inc. (OTCBB:XKEM)

Xechem International, Inc. is a development stage biopharmaceutical company focusing on anticancer, antiviral (including AIDS), antifungal, Sickle Cell Disease (SCD), antimalarial and antibacterial products from natural sources, including microbial and marine organisms. Xechem's mission is to bring relief to the millions of people who suffer from these diseases. Its focus is on the development of phyto-pharmaceuticals and other proprietary technologies, including those used in the treatment of orphan diseases. Its primary attention and resources are currently being directed toward the development and commercial launch of its Sickle Cell drug, NICOSAN(TM)/HEMOXIN(TM), which has shown efficacy in the treatment of SCD.

this is probably the full extent of the pull back for xkem on volume.

get it now for the bounce to $.03.  Then a slow period of consolidation and
new support around $.027-$.03. 

By June, pushing $.15.  Watch and see if you don't want to play.

cheers,
SJ

EOD Running hard! News tomorrow is what I hear...GLTA

Quote from: sir_joke on March 08, 2006, 11:05:43 AM
this is probably the full extent of the pull back for xkem on volume.

get it now for the bounce to $.03.  Then a slow period of consolidation and
new support around $.027-$.03. 

By June, pushing $.15.  Watch and see if you don't want to play.

cheers,
SJ

I was fortunate enough to pick up 200k shares on the pullback to .0125 in the IRA, and this is going to be my first penny to take a chance and just leave it alone.  Sickle cell anmeia is a dreadful disease, and there isn't much out there to my understanding to help in terms of drugs.  I may buy other shares on pull backs and trade them, but I am going to see if this can "go the distance"  I may regret it, but I always talk about taking a chance long on one of these pennies, and this seems as good as any.

A bad day for XKEM........
Broke .02,-25%........
Charts look not so good

Need to remember this chart is being made by the Market makers. This is heavily manipulated and unfortunately not going to be in our favor until a positive pr is out. Probably see some kind of run/close to .021ish tomorrow after a savage intraday beating IMO. My personal account has been decimated by ARCA on this. I read somewhere the pr won't be out until Tuesday. I have no idea if this is true or not. I am hoping they are not bringing this so low that it will only run it up for me to the point of a small profit. Anything on buyins and with arca being the ax does not equal a safe play at all. This is eerily familiar of CKEI GWGO JKRI USXP.... the list goes on and on.

Stochastic's = Oversold